VOGX
Vogenx, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- E Aug 14 Trading halt: Halt Resumed: VOGX — trading resumed after LUDP (Volatilit…
- E Aug 14 Trading halt: Trading Halt: VOGX — LUDP (Volatility Trading Pause)
- E Aug 17 Offering: Jones Served as Sole Book-Running Manager for Vogenx's $81…
- X Aug 31 Short interest falls 29.2% to 18.1K
- A Sep 1 Jones Trading initiates
- A Sep 2 WBB Securities initiates
- X Sep 15 Short interest jumps 40.8% to 25.5K
- X Oct 15 Short interest jumps 42.7% to 38.3K
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- AnalystsBULLISH
7 of 8 rate it Buy or better. Every target is above the price.
- Short sellersBUILDING
Short interest +42.7% to 38.3K shares. 1.0 days to cover, ≈0.3% of shares.
- TrendDOWNTREND
30% below its 50-day average.
The Street
8 analystsPrice is below the lowest target. Median implies +217%.Targets as of Oct 28, 2026.
| Date | Firm | Rating |
|---|---|---|
| Sep 2, 2026 | WBB Securities INITIATE | Speculative Buy |
| Sep 1, 2026 | Jones Trading INITIATE | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 2, 2026 | Toombs Kenneth John Director | AWARD | 50,000 sh |
| Oct 2, 2026 | Pieraccini Peter Director | AWARD | 50,000 sh |
| Oct 2, 2026 | Green James Chief Executive Officer | AWARD | 155,000 sh |
| Oct 2, 2026 | Wilkison William Chief Scientific Officer | AWARD | 155,000 sh |
| Oct 2, 2026 | DELMAR STEVEN R Chief Financial Officer | AWARD | 155,000 sh |
| Oct 2, 2026 | Boris Timothy Director | AWARD | 50,000 sh |
| Aug 13, 2026 | Pieraccini Peter Director | CONVERT | $500.0K |
| Aug 13, 2026 | Pieraccini Peter Director | CONVERT | 500,000 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.07 | -$0.07–-$0.07 | -40.0% | $0.00 |
| Next Q | -$0.33 | -$0.33–-$0.33 | -37.5% | $0.00 |
| Current FY | -$0.69 | -$0.69–-$0.69 | -32.7% | $0.00 |
| Next FY | -$1.65 | -$1.65–-$1.65 | -8.6% | $0.00 |
Short side
FINRA· Oct 15, 2026| Aug 14, 2026 | Volatility Pause | Resumed |
SecBot reports
5 filings · 1 press release · 0 bullish · 0 bearish · 5 neutral- NEUTRAL 8-KOct 9, 2026
Vogenx announced that board member Richard Gorman will become Chief Commercial Officer effective…
Monitor for the appointment of a new independent director and for clinical trial milestones for mizagliflozin in PBH and gastroparesis, which will be the primary value drivers for this…
- NEUTRAL PRESS RELEASEAug 17, 2026
JonesTrading Institutional Services acted as sole book-running manager for Vogenx's $81.3 million…
The press release is from the underwriter, not the issuer. Monitor Vogenx for its first earnings report as a public company and any pipeline updates for PBH/gastroparesis. The IPO provides ~$81M in…
- NEUTRAL 3Aug 11, 2026
Timothy Boris filed an initial Form 3 with the SEC, disclosing beneficial ownership of Vogenx…
This is a standard initial ownership filing by an insider. No actionable trading signal — monitor future Form 4 filings for any open-market purchases or sales by Boris, which would provide more…
- NEUTRAL 3Aug 11, 2026
Steven R. Delmar filed a Form 3 initial statement of beneficial ownership upon becoming an insider…
This Form 3 is a routine insider onboarding filing with no trading signal. Monitor for future Form 4 filings to track any open-market purchases or sales by the CFO, which would provide actionable…
All VOGX filing & press-release reports (6)
- 8-K reportOct 9, 2026
- PRESS-RELEASE reportAug 17, 2026
- 3 reportAug 11, 2026
- 3 reportAug 11, 2026
- S-1/A reportAug 10, 2026
- S-1/A reportJul 29, 2026